• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL4:NLRP3 介导的细胞焦亡产物,调节心肌纤维化。

CXCL4:NLRP3-mediated pyroptosis product that regulates cardiac fibrosis.

机构信息

Department of Laboratory Medicine, Nanjing First Hospital, Nanjng Medical University, Nanjing 210006, China.

Department of Laboratory Medicine, Jiangning Hospital Affiliated to Nanjng Medical University, Nanjing 211100, China.

出版信息

Int Immunopharmacol. 2024 May 30;133:112096. doi: 10.1016/j.intimp.2024.112096. Epub 2024 Apr 23.

DOI:10.1016/j.intimp.2024.112096
PMID:38657496
Abstract

Severe myocarditis is often accompanied by cardiac fibrosis, but the underlying mechanism has not been fully elucidated. NOD-like receptor protein 3 (NLRP3) inflammation is involved in the development of myocarditis and is closely related to the form of cell death. Inhibiting pyroptosis mediated by NLRP3 inflammasome can reduce cardiac fibrosis, although its exact mechanism remains unknown. In this study, we induced Viral myocarditis (VMC) via infection of CVB3 to explore the relationship between pyroptosis and fibrosis. Our results showed that intraperitoneal injection of an NLRP3 inhibitor MCC950 or use of NLRP3 mice inhibited cardiac pyroptosis mediated by NLRP3 inflammasome in VMC. CXCL4 is a chemokine that has been reported to have pro-inflammatory and pro-fibrotic functions. In VMC, we further found that pyroptosis of Mouse myocardial fibroblasts (MCF) promoted the secretion of CXCL4 by activating Wnt/β-Catenin signaling. Subsequently, the transcriptome sequencing data showed that CXCL4 could promote cardiac fibrosis by activating PI3K/AKT pathway. In summary, infection of CVB3 induced host oxidative stress to further activate the NLRP3 inflammasome and ultimately lead to heart pyroptosis, in which MCF secreted CXCL4 by activating Wnt/β-Catenin signaling and CXCL4 participated in cardiac fibrosis by activating PI3K/AKT pathway. Therefore, our findings revealed the role of CXCL4 in VMC and unveiled its underlying mechanism. CXCL4 appears to be a potential target for the treatment of VMC.

摘要

严重心肌炎常伴有心肌纤维化,但其中的机制尚未完全阐明。NOD 样受体蛋白 3(NLRP3)炎症参与了心肌炎的发展,并且与细胞死亡的形式密切相关。抑制 NLRP3 炎性小体介导的细胞焦亡可以减少心肌纤维化,尽管其确切机制尚不清楚。在这项研究中,我们通过感染 CVB3 诱导病毒性心肌炎(VMC),以探索细胞焦亡与纤维化之间的关系。我们的结果表明,腹腔注射 NLRP3 抑制剂 MCC950 或使用 NLRP3 敲除小鼠可抑制 VMC 中 NLRP3 炎性小体介导的心脏细胞焦亡。趋化因子 CXCL4 已被报道具有促炎和促纤维化作用。在 VMC 中,我们进一步发现,心肌成纤维细胞(MCF)的细胞焦亡通过激活 Wnt/β-Catenin 信号通路促进 CXCL4 的分泌。随后,转录组测序数据显示,CXCL4 通过激活 PI3K/AKT 通路促进心脏纤维化。总之,CVB3 感染诱导宿主氧化应激,进一步激活 NLRP3 炎性小体,最终导致心脏细胞焦亡,其中 MCF 通过激活 Wnt/β-Catenin 信号通路分泌 CXCL4,而 CXCL4 通过激活 PI3K/AKT 通路参与心脏纤维化。因此,我们的研究结果揭示了 CXCL4 在 VMC 中的作用及其潜在机制。CXCL4 似乎是治疗 VMC 的一个有潜力的靶点。

相似文献

1
CXCL4:NLRP3-mediated pyroptosis product that regulates cardiac fibrosis.CXCL4:NLRP3 介导的细胞焦亡产物,调节心肌纤维化。
Int Immunopharmacol. 2024 May 30;133:112096. doi: 10.1016/j.intimp.2024.112096. Epub 2024 Apr 23.
2
MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.MCC950通过抑制NLRP3介导的细胞焦亡减轻阿霉素在体内和体外诱导的心肌损伤。
Biomed Pharmacother. 2021 Nov;143:112133. doi: 10.1016/j.biopha.2021.112133. Epub 2021 Aug 31.
3
CXCL4/CXCR3 axis regulates cardiac fibrosis by activating TGF-β1/Smad2/3 signaling in mouse viral myocarditis.CXCL4/CXCR3 轴通过激活 TGF-β1/Smad2/3 信号通路调节小鼠病毒性心肌炎中的心肌纤维化。
Immun Inflamm Dis. 2024 Apr;12(4):e1237. doi: 10.1002/iid3.1237.
4
Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis.线粒体钙蛋白酶-1 通过切割 ATP5A1 并诱导 CVB3 诱导的心肌炎中的线粒体 ROS 来激活 NLRP3 炎性体。
Basic Res Cardiol. 2022 Aug 23;117(1):40. doi: 10.1007/s00395-022-00948-1.
5
Role of deubiquitinase USP47 in cardiac function alleviation and anti-inflammatory immunity after myocardial infarction by regulating NLRP3 inflammasome-mediated pyroptotic signal pathways.去泛素化酶 USP47 通过调节 NLRP3 炎性体介导热激性细胞死亡信号通路在心肌梗死后心脏功能缓解和抗炎免疫中的作用。
Int Immunopharmacol. 2024 Jul 30;136:112346. doi: 10.1016/j.intimp.2024.112346. Epub 2024 Jun 7.
6
MG53 protects against Coxsackievirus B3-induced acute viral myocarditis in mice by inhibiting NLRP3 inflammasome-mediated pyroptosis via the NF-κB signaling pathway.MG53 通过抑制 NLRP3 炎性体介导线粒体依赖性细胞凋亡途径抑制 NF-κB 信号通路来保护小鼠免受柯萨奇病毒 B3 诱导的急性病毒性心肌炎。
Biochem Pharmacol. 2024 May;223:116173. doi: 10.1016/j.bcp.2024.116173. Epub 2024 Mar 27.
7
Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia.MCC950 和 VX-765 这两种焦亡抑制剂通过减轻急性心肌缺氧中的氧化应激、炎症和细胞凋亡来减轻心肌损伤。
Exp Cell Res. 2024 May 15;438(2):114061. doi: 10.1016/j.yexcr.2024.114061. Epub 2024 Apr 30.
8
IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis.IL-37 通过抑制 NLRP3 炎性体介导的细胞焦亡缓解柯萨奇病毒 B3 诱导的病毒性心肌炎。
Sci Rep. 2022 Nov 22;12(1):20077. doi: 10.1038/s41598-022-22617-y.
9
The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.选择性 NLRP3 炎性体抑制剂 MCC950 可减少心肌梗死后小鼠的心肌纤维化并改善心脏重构。
Int Immunopharmacol. 2019 Sep;74:105575. doi: 10.1016/j.intimp.2019.04.022. Epub 2019 Jul 9.
10
NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation.NLRP3 炎性小体抑制通过减少氧化应激和炎症来减轻顺铂诱导的肾纤维化。
Exp Cell Res. 2019 Oct 1;383(1):111488. doi: 10.1016/j.yexcr.2019.07.001. Epub 2019 Jul 2.

引用本文的文献

1
Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications.心血管疾病中的细胞焦亡:作用、机制及临床意义
Front Cardiovasc Med. 2025 Aug 4;12:1629016. doi: 10.3389/fcvm.2025.1629016. eCollection 2025.
2
Functional transformation of macrophage mitochondria in cardiovascular diseases.心血管疾病中巨噬细胞线粒体的功能转变
Mol Cell Biochem. 2025 Feb;480(2):747-757. doi: 10.1007/s11010-024-05049-2. Epub 2024 Jun 17.